Cordlife Fails to Acquire Blood Service License From MOH
Cordlife Fails to Acquire Blood Service License From MOH
Cordilife had earlier said that it does not intend to submit a written representation to the MOH regarding the third notice. It is expected to continuously impact its finances negatively.
預計將持續對其財務產生負面影響。
Cordilife Group has warned investors that its inability to resume full operations will "continuously impact its finances negatively" for the fiscal year ending 31 December 2024.
Cordilife集團已警告投資者，其無法恢復全面運營將"持續對其財務產生負面影響"，截至2024年12月31日的財政年度。
In a bourse filing, Cordilife said that it is able to resume its cord blood banking service operations limitedly, with the MOH limiting the company's collection, testing, processing, and storing of new cord blood from infant donors to no more than 30 units per month until 13 January 2025.
Cordilife在證券交易所文件中表示，公司能夠有限地恢復臍帶血庫存儲服務的運營，但衛生部限制公司從嬰兒供體收集、檢測、處理和存儲新臍帶血的數量，直到2025年1月13日之前，每月不得超過30個單位。
Cordilife had earlier said that it does not intend to submit a written representation to the MOH regarding the third notice.
Cordilife此前表示，不打算向衛生部提交關於第三通知的書面材料。
